Doxorubicin Hydrochloride (Athenex Pharmaceutical Division, LLC.)
Welcome to the PulseAid listing for the Doxorubicin Hydrochloride drug offered from Athenex Pharmaceutical Division, LLC.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Athenex Pharmaceutical Division, LLC. |
| NON-PROPRIETARY NAME: | doxorubicin hydrochloride |
| SUBSTANCE NAME: | DOXORUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-10-20 |
| END MARKETING DATE: | 0000-00-00 |
Doxorubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Doxorubicin Hydrochloride from Athenex Pharmaceutical Division, LLC. |
| LABELER NAME: | Athenex Pharmaceutical Division, LLC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2017-10-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70860-208_93ce419e-e621-46a8-9e35-b818a569a18a |
| PRODUCT NDC: | 70860-208 |
| APPLICATION NUMBER: | ANDA209825 |
Other DOXORUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
